Abstract

Motivational and attentional processes energize action sequences to facilitate evolutionary competition and promote behavioral fitness. Decades of neuropharmacology, electrophysiology and electrochemistry research indicate that the mesocorticolimbic DA pathway modulates both motivation and attention. More recently, it was realized that mesocorticolimbic DA function is tightly regulated by the brain’s endocannabinoid system and greatly influenced by exogenous cannabinoids—which have been harnessed by humanity for medicinal, ritualistic, and recreational uses for 12,000 years. Exogenous cannabinoids, like the primary psychoactive component of cannabis, delta-9-tetrahydrocannabinol, produce their effects by acting at binding sites for naturally occurring endocannabinoids. The brain’s endocannabinoid system consists of two G-protein coupled receptors, endogenous lipid ligands for these receptor targets, and several synthetic and metabolic enzymes involved in their production and degradation. Emerging evidence indicates that the endocannabinoid 2-arachidonoylglycerol is necessary to observe concurrent increases in DA release and motivated behavior. And the historical pharmacology literature indicates a role for cannabinoid signaling in both motivational and attentional processes. While both types of behaviors have been scrutinized under manipulation by either DA or cannabinoid agents, there is considerably less insight into prospective interactions between these two important signaling systems. This review attempts to summate the relevance of cannabinoid modulation of DA release during operant tasks designed to investigate either motivational or attentional control of behavior. We first describe how cannabinoids influence DA release and goal-directed action under a variety of reinforcement contingencies. Then we consider the role that endocannabinoids might play in switching an animal’s motivation from a goal-directed action to the search for an alternative outcome, in addition to the formation of long-term habits. Finally, dissociable features of attentional behavior using both the 5-choice serial reaction time task and the attentional set-shifting task are discussed along with their distinct influences by DA and cannabinoids. We end with discussing potential targets for further research regarding DA-cannabinoid interactions within key substrates involved in motivation and attention.

Highlights

  • It is recognized that 2AG and AEA have different synthetic and metabolic pathways (Lu and Mackie, 2016). 2AG is predominantly synthesized from 2-arachidonoyl-containing phospholipids by DAG lipase (DAGL) and metabolized by monoacylglycerol lipase (MAGL); AEA is predominantly synthesized from N-acyl-phosphatidylethanolamine (NAPE) by NAPE-specific phospholipase D (NAPE-PLD) and metabolized by fatty acid amidohydrolase (FAAH) (Lu and Mackie, 2016; Toczek and Malinowska, 2018; Zou and Kumar, 2018)

  • Their finding that AM251 reduced responding for sugar pellets, the authors concluded that mice increased responding after the series of AM251 treatments because they had not been reaching satiety across the variable interval (VI) training sessions and were showing an increase in goal-directed appetitive behavior rather than habitual responding during the first contingency degradation session

  • It becomes difficult to definitively know whether a striatal DA transient truly reflects the value of a desired outcome within a motivational context, is the result of an animal responding to a pre-attentive visual stimulus or is the result of an animal giving a visual stimulus attentional consideration

Read more

Summary

Introduction

Statement of PurposeBecause many reviews already exist that describe endocannabinoid (eCB) signaling (Toczek and Malinowska, 2018; Zou and Kumar, 2018; Cristino et al, 2020; Kaczocha and Haj-Dahmane, 2021), the risks of cannabis abuse (Ferland and Hurd, 2020; Hindley et al, 2020), and the potential cannabinoids may offer in psychiatric medicine (Amar, 2006; Black et al, 2019; Navarrete et al, 2020), our goal in the present manuscript is to describe how exogenous cannabinoids and eCBs influence dopamine (DA) signaling and behavior. 535 chemicals and 90 different C21 terpenophenolic phytocannabinoids exist in the cannabis plant (Radwan et al, 2009; Andre et al, 2016) While these chemicals act synergistically to produce an entourage effect with delta-9-tetrahydrocannabinol (THC), the latter is principally responsible for cannabis’s psychoactive effects by activating G protein-coupled receptors (GPCR) in the brain (e.g., cannabinoid receptor type 1; CB1) (Casajuana Kögel et al, 2018; Russo, 2019). While modern terminology surrounding attention may refer to disparate concepts such as arousal, vigilance, and distractibility, it may be broadly defined as selective activation of neural representations during information processing. Through this definition, attention may be best illustrated in relation to the highly related process of working memory. Deficits in attentional control are potential barriers to adaptive behavior and overall survivability of the organism, with pathologies affecting this executive function leading to maladaptive traits that negatively impact quality of life (Baddeley et al, 2001; Rueda et al, 2004; Williams-Gray et al, 2008; Burgess et al, 2010; Fajkowska and Derryberry, 2010; Schoorl et al, 2014; Stefanopoulou et al, 2014; Heeren and McNally, 2016)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call